Parathyroid Hormone as a Therapy for Idiopathic Osteoporosis in Men: Effects on Bone Mineral Density and Bone Markers<sup>1</sup>
Etah S. Kurland(Columbia University), John P. Bilezikian(Columbia University), Felicia Cosman(Helen Hayes Hospital), Clifford J. Rosen(MaineHealth), R. Lindsay(University of Manchester), Donald J. McMahon(Center for Clinical Research (United States))
Cited by 361
Related Papers
Clinician’s Guide to Prevention and Treatment of Osteoporosis
|Osteoporosis International|2014|4.1k
The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know
|The Journal of Clinical Endocrinology & Metabolism|2010|4k
Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions
|Endocrine Reviews|2018|1.1k
LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGEN
|The Lancet|1976|956